Where do Dogwood Therapeutics's ratios come from?

Every ratio is computed from Dogwood Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-64.6%+387pp	——	-931%-730pp	-494.1%-375pp	-451.3%-334pp
Return on assets	-29.5%+14.4pp	-37.1%-12.1pp	-81%+71.0pp	-49.3%+56.5pp	-43.9%+60.2pp
Liquidity
Current ratio	5.9×-1.6×	2.8×-2.5×	4.5×+2.8×	7.8×+0.5×	7.4×+1.8×
Quick ratio	5.9×-1.6×	2.8×-2.5×	4.5×+2.8×	7.8×+0.5×	7.4×+1.8×
Cash ratio	5.2×-1.6×	2.1×-2.5×	3.9×+2.4×	7.1×+1.1×	6.8×+2.6×
Leverage
Debt-to-equity	0×0.0×	0×—	0×—	0×—	0×—
Debt-to-assets	0×0.0×	0×0.0×	0×—	0×—	0×—
Interest coverage	-89×—	-288.5×—	——	——	——
Per Share
Book value per share	$2.40-51.1%	$15.05+253%	$3.78+342%	$3.60+5.1%	$4.92+42.7%
Valuation
Market capitalization	$54.14M-57.6%	$123.67M+188%	$228.9M—	$120.16M—	$124.12M—
Enterprise value	$41.06M-64.7%	$117.31M+314%	$218.95M—	$106.94M—	$106.78M—
Price / book	0.6×-16.6×	1.7×—	31.5×—	17.5×—	17.5×—
Earnings yield	-56.5%-35.6pp	-27.7%+1.0pp	-16.7%—	-20.6%—	-17.7%—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Dogwood Therapeutics's ratios come from?: Every ratio is computed from Dogwood Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.